Reference health
Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients
35/35 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 35 checked references that resolve
resolves10.1016/S1470-2045(13)70436-4
Management of gastric cancer in Asia: resource-stratified guidelines
resolves10.1093/oxfordjournals.annonc.a058778
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer
resolves10.1038/bjc.1995.114
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
resolves10.1146/annurev.med.57.121304.131240
Cardiotoxicity Induced by Chemotherapy and Antibody Therapy
resolves10.2174/157340311799960645
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
resolves10.1586/14737140.7.12.1763
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
resolves10.1016/S0140-6736(07)61865-0
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
resolves10.1007/BF03006439
Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: Comparative study with myocardial perfusion, left ventricular function, and histopathological findings
resolves10.1002/ejhf.592
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
resolves10.3322/caac.21341
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
resolves10.1200/JCO.2007.13.9378
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
resolves10.1016/S1470-2045(13)70102-5
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
resolves10.1016/j.ejca.2017.02.009
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
resolves10.1159/000471759
A Prospective Study to Evaluate the Effect of Paclitaxel on Cardiac Ejection Fraction
resolves10.1200/JCO.2017.35.4_suppl.553
Cardiotoxicity in Chinese cancer patients treated with 5-fluorouracil or capecitabine: A multicenter prospective observational study.
resolves10.1016/j.ctrv.2013.03.005
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
resolves10.1007/s00432-007-0250-9
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
resolves10.1007/s00280-005-0178-1
Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine
resolves10.1093/annonc/mdf108
Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil
resolves10.1038/bjc.1998.12
The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate
resolves10.1038/sj.bjc.6601224
Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil
resolves10.1093/annonc/mdr348
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
resolves10.1007/s12094-016-1508-y
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
resolves10.1200/JCO.2016.67.4846
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
resolves10.3748/wjg.v21.i21.6631
High morbidity in myocardial infarction and heart failure patients after gastric cancer surgery
resolves10.1007/s11739-015-1362-x
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer
resolves10.1016/j.disamonth.2005.03.010
Deep Vein Thrombosis and Cancer: Survival, Recurrence, and Anticoagulant Choices
resolves10.1200/JCO.2000.18.17.3078
Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis
resolves10.1093/jnci/djp440
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
resolves10.1155/2015/671232
Clinical Experience of Patients Referred to a Multidisciplinary Cardiac Oncology Clinic: An Observational Study
The 3 references without a DOI — listed, not checked
no DOI — not checkedGLOBOCAN2018: Estimated cancer incidence, mortality and prevalence worldwide in 2018.
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
. Accessed 2019
no DOI — not checkedCommon Terminology Criteria for Adverse Events.
http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0
. Accessed 2019
no DOI — not checkedKhan MA, Masood N, Husain N, Ahmad B, Aziz T, Naeem A (2012) A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center. JPMA J Pak Med Assoc 62(5):430–434
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s00280-019-03888-1"><img src="https://citestamp.com/citestamped/10.1007/s00280-019-03888-1/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s00280-019-03888-1)